Quetiapine Compared With Placebo in the Management of Fibromyalgia

NCT01458964 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2014-07-09

No results posted yet for this study

Summary

Is quetiapine more effective than other medications in the treatment of fibromyalgia.

Conditions

  • Fibromyalgia

Interventions

DRUG

Quetiapine

100 mg (peach colored oblong tablet) and 200 mg (yellow colored oblong tablet)

Sponsors & Collaborators

  • AstraZeneca

    collaborator INDUSTRY
  • East Tennessee State University

    lead OTHER

Principal Investigators

  • Norman C Moore, M.D. · East Tennessee State University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01458964 on ClinicalTrials.gov